Related references
Note: Only part of the references are listed.Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study
Daniel Aletaha et al.
LANCET (2017)
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors
Vibeke Strand et al.
RMD OPEN (2017)
Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis
Faith Matcham et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
Interleukin-6: an emerging regulator of pathological pain
Ya-Qun Zhou et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways
John A. Sturgeon et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
Pietro Enea Lazzerini et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Integrating Interleukin-6 into depression diagnosis and treatment
Georgia E. Hodes et al.
NEUROBIOLOGY OF STRESS (2016)
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
Vibeke Strand et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Interleukin-6 as a predictor of symptom resolution in psychological distress: a cohort study
M. Virtanen et al.
PSYCHOLOGICAL MEDICINE (2015)
Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials
Ana-Maria Orbai et al.
CURRENT RHEUMATOLOGY REPORTS (2015)
A Mechanism-Based Approach to the Management of Osteoarthritis Pain
Ezra Cohen et al.
CURRENT OSTEOPOROSIS REPORTS (2015)
Fatigue in chronic inflammation - a link to pain pathways
Karine Louati et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis
Laure Gossec et al.
RMD OPEN (2015)
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
IL-6 biology: implications for clinical targeting in rheumatic disease
Leonard H. Calabrese et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress
Georgia E. Hodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
Juergen Scheller et al.
SEMINARS IN IMMUNOLOGY (2014)
Nociceptive neurons detect cytokines in arthritis
Hans-Georg Schaible
ARTHRITIS RESEARCH & THERAPY (2014)
Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results
Roy M. Fleischmann et al.
JOURNAL OF RHEUMATOLOGY (2013)
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay et al.
LANCET (2013)
Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress
Milena Girotti et al.
PSYCHONEUROENDOCRINOLOGY (2013)
The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review
Alan M. Rathbun et al.
RHEUMATOLOGY (2013)
The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis
Faith Matcham et al.
RHEUMATOLOGY (2013)
Fatigue and Factors Related to Fatigue in Rheumatoid Arthritis: A Systematic Review
Stephanie Nikolaus et al.
ARTHRITIS CARE & RESEARCH (2013)
Effect and Treatment of Chronic Pain in Inflammatory Arthritis
Yvonne C. Lee
CURRENT RHEUMATOLOGY REPORTS (2013)
Role of interleukin-6 in stress, sleep, and fatigue
Nicolas Rohleder et al.
NEUROIMMUNOMODULATION IN HEALTH AND DISEASE I (2012)
Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction
Marni N. Silverman et al.
NEUROIMMUNOMODULATION IN HEALTH AND DISEASE I (2012)
Spinal interleukin-6 is an amplifier of arthritic pain in the rat
Enrique Vazquez et al.
ARTHRITIS AND RHEUMATISM (2012)
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Masahiko Mihara et al.
CLINICAL SCIENCE (2012)
IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
Stefan Rose-John
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Sleep Disturbances and Interleukin 6 Receptor Inhibition in Rheumatoid Arthritis
Kalliopi Fragiadaki et al.
JOURNAL OF RHEUMATOLOGY (2012)
Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome
Andrew S. Papadopoulos et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis
Ernest Choy
RHEUMATOLOGY (2012)
Fatigue in rheumatoid arthritis and its relation to interleukin-6 serum level
Abdel Moneim H. Helal et al.
EGYPTIAN RHEUMATOLOGIST (2012)
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2011)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Measures of Adult Pain Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)
Gillian A. Hawker et al.
ARTHRITIS CARE & RESEARCH (2011)
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
G. Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Excess Mortality Emerges After 10 Years in an Inception Cohort of Early Rheumatoid Arthritis
B. J. Radovits et al.
ARTHRITIS CARE & RESEARCH (2010)
Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis
Michael K. Boettger et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Depression, Inflammation, and Pain in Patients With Rheumatoid Arthritis
Masayo Kojima et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
A Key Role for gp130 Expressed on Peripheral Sensory Nerves in Pathological Pain
Manfred Andratsch et al.
JOURNAL OF NEUROSCIENCE (2009)
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment
S. J. Bull et al.
MOLECULAR PSYCHIATRY (2009)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Comorbid depression in rheumatoid arthritis: Pathophysiology and clinical implications
Travis O. Bruce
Current Psychiatry Reports (2008)
Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat - An inflammatory mechanism of joint pain
Daniel Brenn et al.
ARTHRITIS AND RHEUMATISM (2007)
Patients' perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored
S Hewlett et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Acute and long-term effects of IL-6 on cultured dorsal root ganglion neurones from adult rat
GS von Banchet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons
O Obreja et al.
BRAIN (2005)
Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection
MN Silverman et al.
VIRAL IMMUNOLOGY (2005)
IL-6 and its circadian secretion in humans
AN Vgontzas et al.
NEUROIMMUNOMODULATION (2005)
Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis
T Heiberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Impact of fatigue on health-related quality of life in rheumatoid arthritis
I Rupp et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
C Tsigos et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms
S Bonaccorso et al.
PSYCHIATRY RESEARCH (2001)
Predictors of radiographic joint damage in patients with early rheumatoid arthritis
LMA Jansen et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis
EF Morand et al.
IMMUNOLOGY AND CELL BIOLOGY (2001)
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses
T Jostock et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Share Paper
